Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

172.21
Delayed Data
As of Oct 19
 -0.74 / -0.43%
Today’s Change
95.14
Today|||52-Week Range
175.72
+52.83%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues103.0M114.7M124.7M132.5M
 
 
 
 
 
Cost of Goods Sold15.8M17.5M17.5M19.4M
 
 
 
 
 
Depreciation And Amortization1.6M1.5M1.7M2.5M
 
 
 
 
 
 
Operating ExpensesGross Income85.6M95.7M105.4M110.6M
 
 
 
 
 
General Expenses71.1M69.9M76.4M77.3M
 
 
 
 
 
Research And Development18.0M15.9M16.3M16.7M
 
 
 
 
 
Total Operating Expenses88.4M88.8M95.7M99.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income14.5M25.8M29.0M33.3M
 
 
 
 
 
Extraordinary Charge-10.0K-426.0K0.00-265.0K
 
 
 
 
Other Expenses-114.0K-34.0K-124.0K79.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income14.7M25.8M29.4M33.8M
 
 
 
 
 
Income Taxes-5.9M-10.4M-14.5M-3.6M
 
 
 
 
 
Net Income8.9M15.4M14.9M37.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS43.1M43.4M43.6M43.9M
 
 
 
 
 
Shares To Calculate EPS Diluted44.6M44.8M44.9M45.6M
 
 
 
 
 
 
Earnings Per ShareEPS$0.20$0.34$0.33$0.82
 
 
 
 
 
EPS Diluted$0.20$0.34$0.33$0.82